Angiotensinogen and blood pressure among blacks: Findings from a community survey in Jamaica

Journal of Hypertension

Volumn 14, Issue 3, 1996, Pages 315-321

  Forrester, Terrence ^a   McFarlane Anderson, Norma ^a   Bennet, Franklyn ^a   Wilks, Rainford ^a   Puras, Angel ^b   Cooper, Richard ^b   Rotimi, Charles ^b   Durazo, Ramon ^b   Tewksbury, Duane ^c   Morrison, Linda ^d  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c MARSHFIELD CLINIC   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Blacks; Blood pressure; Gene; Obesity

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; DEMOGRAPHY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTENSION; JAMAICA; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKINFOLD THICKNESS; VENOUS BLOOD;

EID: 9244236521     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199603000-00007     Document Type: Article

References (47)

1. Inagami T: The renin-angiotensin system. Essays Biochem 1994, 28:147-164.
2. Tewksbury DA: Angiotensinogen. Fed Proc 1983, 42:2724-2728.
3. Molecular biology of the renin-angiotensin system: implications for hypertension and beyond. J Cardiovasc Pharm 1991, 18 (suppl 2):S1-S6.
4. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
5. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994, 90:2207-2212.
6. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330:1629-1633.
7. Herrera VLM, Ruiz-Opazo N: Beyond genetic markers: hypertension genes. J Hypertens 1994, 12:847-856.
8. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al.: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic cardiomyopathy. Lancet 1993, 342:1073-1065.
9. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al.: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994, 90:669-676.
10. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al.: Deletion polymorphism in angiotensin-converting enzyme gene associated with parenteral history of myocardial infarction. Lancet 1993, 341:991-992.
11. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
12. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
13. Walker WG, Whelton PK, Saito H, Russell RP, Hermann J: Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979, 1:287-291.
14. Fasola AF, Martz BL, Helmer OM: Plasma renin activity during supine exercise in offspring of hypertensive parents. J Appl Physiol 1968, 25:410-415.
15. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edward HV, Davidson HR, et al.: Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach. J Hypertens 1992, 10:473-482.
16. Forrester T, McFarlane N, Bennett FI, Wilks R, Cooper R, Rotimi C, et al.: The insertion/deletion polymorphism of the ACE gene, serum ACE activity and blood pressure in Jamaicans. Hypertension submitted.
17. Alhenc-Gelas F, Richard J, Corbon D, Warner JM, Corvol P: Distribution of plasma angiotensin-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med 1991, 117:33-39.
18. Niarchos AP, Resnick LM, Weinstein DL, Laragh JH: Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles and antihypertensive therapy. Am J Med 1985, 79:435-444.
19. Dux S, Aron N, Boner G, Carmel A, Taron A, Rosenfeld JB: Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension. Isr J Med Sci 1984, 20:1138041.
20. Cambien F, Alhenc-Gelas F, Berbeth B, Andre JL, Rakotovao R, Gonzales MJ, et al.: Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet 1988, 43:774-780.
21. Arngrimsson R, Purandare S, Conner M: Angiotensinogen: a candidate gene involved in preeclampsia? Nature Genet 1993, 4:114-115.
22. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Nbarnikawa C, et al.: A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993, 4:59-61.
23. Fray JCS: (Pro)renin processing and secretion in black essential hypertension and other low-renin syndromes. In Pathophysiology of Hypertension in Blacks. Edited by Fray JCS, Douglas JG. New York: Oxford University Press; 1993:214-238.
24. Falkner B: Differences in blacks and whites with essential hypertension: biochemistry and endocrine [state of the art lecture]. Hypertension 1990, 15:681-686.
25. Holland OM, Gomez-Sanchez C, Fairchild A, Kaplan N: Role of renin classification for diuretic treatment of black hypertensive patients. Arch Intern Med 1979, 139:1365-1370.
26. Fisher MDL, Gleason RE, Moore TJ, Williams GH, Hollenberg NK: Regulation of aldosterone secretion in hypertensive blacks. Hypertension 1994, 23:179-184.
27. Rutledge D, Browe C, Kublis P, Ross E: Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertens 1994, 7:651-654.
28. Rotimi C, Morrison, Cooper R, Oyejide C, Effiong E, Ladipo M, et al.: Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994, 24:591-594.
29. Ataman S, Cooper R, Rotimi C, Osotimehin B, Muna W, Kingue S, et al.: Standardization of blood pressure in an international collaborative study. J Clin Epidemiol (In press).
30. Tewksbury DA, Dart RA: High molecular weight angiotensinogen levels in pregnant women. Hypertension 1982, 4:729-734.
31. Beneteau B, Baudin B, Morgant G, Giboudeau J, Baumann FC: Automated kinetic assay of angiotensin converting enzyme activity in serum. Clin Chem 1986, 32:884-886.
32. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/ deletion polymorphism of the human angiotensin-converting enzyme gene (DCP 1 dipeptldyl carboxypeptidase). Nucleic Acids Res 1992, 20:1433.
33. Ludwig E, Cornell PS, Anderson JL, Marshal HW, Lalouel J-M, Ward RH: Coronary stenosis precedes increased genetic risk of myocardial Infarction associated with the angiotensin-converting enzyme gene. Circulation 1995, 91:2120-2124.
34. Cassis AL, Saye JA, Peach MJ: Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988, 11:591-596.
35. Eggena P, Sowers J, Maxwell MH, Barrett JD, Bolulb MS: Hormonal correlates of weight loss associated with blood pressure reduction. Clin Exp Hypertens[A] 1991, 13:1447-1456.
36. Frederich RC Jr, Kahn BB, Peach MJ, Flier JS: Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339-344.
37. Cassis LA, Lynch KR, Peach MJ: Localization of angiotensinogen mRNA in rat aorta. Circ Res 1988, 62:1259-1262.
38. Phillips MI, Speakman EA, Kimura B: Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Peptides 1993, 434:1-120.
39. Krege JH, Hohm SWM, Hadgin-Hagaman JR, Smithis O: An animal model for studying the role of angiotensin-converting enzyme (ACE) in cardiovascular diseases [abstract]. Hypertension 1994, 23:374.
40. Kamdar S, Daniel H, Fogarty P, Lawson M, Munroe P, Cauffield M: ACE insertion/deletion polymorphism in Vincentian African Caribbeans with essential hypertension [abstract]. J Hum Hypertens 1994, 8:611.
41. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994, 93:1285-1287.
42. Adams JP, Ward RH: Admixture studies and the detection of selection. Science 1973, 180:1137-1143.
43. Chakraborty R, Kamboh MI, Nwanko M, Ferrell RE: Caucasian genes in American blacks: new data. Am J Hum Genet 1992, 50:145-155.
44. Cooper RS, Rotimi CN: Hypertension in populations of West African origin: is there a genetic predisposition? J Hypertens 1994, 12:215-227.
45. Ogunlesi A, Osotimehin B, Abbiyessuku F, Kadiri S, Akinkugbe O, Liao Y, et al.: Blood pressure and education level among factory workers in Ibadan, Nigeria. J Hum Hypertens 1991, 5:375-380.
46. Foster C, Rotimi C, Fraser H, Sundarum C, Liao Y, Gibson E, et al.: Hypertension diabetes and obesity in Barbados: findings from a recent population-based survey. Ethnicity Dis 1993, 3:404-412.
47. Akinkubge OO: World epidemiology of hypertension in blacks. In Hypertension in Blacks. Edited by Hall WD, Saunders E, Shulman NB. Chicago, IL: Year Book Medical Publishers Inc.; 1985:3-16.